Feasibility of Total Gastrectomy with D2 Lymphadenectomy for Gastric Cancer and Predictive Factors for Its Short- and Long-Term Outcomes
|
|
- Thomas Cameron
- 6 years ago
- Views:
Transcription
1 DOI /s x ORIGINAL ARTICLE Feasibility of Total Gastrectomy with D2 Lymphadenectomy for Gastric Cancer and Predictive Factors for Its Short- and Long-Term Outcomes Fan-Feng Chen 1 & Dong-Dong Huang 1 & Jin-Xiao Lu 1 & Chong-Jun Zhou 1 & Cheng-Le Zhuang 1 & Su-Lin Wang 1 & Xian Shen 1 & Zhen Yu 1,2 & Xiao-Lei Chen 1 Received: 11 August 2015 /Accepted: 10 December 2015 # 2015 The Society for Surgery of the Alimentary Tract Abstract Background The aim of this study was to evaluate the short- and long-term outcomes after total gastrectomy (TG) with D2 lymphadenectomy. Methods Patients undergoing TG with D2 lymphadenectomy for gastric cancer between December 2008 and December 2011 were enrolled. Univariate and multivariate analyses were performed to evaluate the risk factors for the short- and long-term outcomes. Results A total of 229 patients were analyzed, and 22.3 % developed complications within 30 days of surgery. No patient died within 30 days, while 2.6 % died within 90 days of the operation. In the multivariate analysis, age 65 years and cardiopulmonary comorbidities were associated with morbidity, whereas hypoproteinemia and tumor node metastasis (TNM) stage III were associated with the disease-free survival (DFS) and overall survival (OS). The number of preoperative risk factors stratified the morbidity from 10.3 % in those without any risk factors to 40.5 % in patients with both risk factors. Similarly, 5-year survival rates decreased from 68.9 % (DFS) and 71.1 % (OS) in those without risk factors to 20.2 % (DFS) and 22.9 % (OS) in patients with both risk factors. Conclusion TG with D2 lymphadenectomy has acceptable short- and long-term outcomes. Patient risk stratification may allow for more rational selection of patients and therapeutic strategies for gastric resection. Keywords Total gastrectomy. D2 lymphadenectomy. Morbidity. Mortality. Survival Fan-Feng Chen and Dong-Dong Huang contributed equally to this work. * Zhen Yu yuzhen0577@gmail.com * Xiao-Lei Chen chenxiaolei0577@126.com 1 2 Department of Gastrointestinal Surgery, The First Affiliated Hospital of Wenzhou Medical University, 2 Fuxue Lane, Wenzhou , Zhejiang, China Department of Surgery, Shanghai Tenth People s Hospital Affiliated to TongJi University, Shanghai , China Introduction Despite a decrease in its incidence, gastric cancer is still the fifth most common malignancy and the third leading cause of cancer-related death worldwide. 1 In Eastern Asia, including Japan, Korea, and China, gastric cancer is one of the most prevalent types of cancer. 2 Surgical resection has remained the mainstay of treatment for gastric cancer for decades and currently provides the only hope for long-term survival. 3 According to the Japanese treatment guidelines for gastric cancer, 4 total gastrectomy (TG) with a proper extent of lymphadenectomy should be adopted for upper and middle-third gastric carcinoma, advanced esophagogastric junction tumor, or huge gastric tumors. Compared with subtotal gastrectomy, TG is considered to result in a higher occurrence of postoperative morbidity and mortality. 5,6 Radical gastrectomy with D2 lymphadenectomy is the standard surgical procedure for the treatment of resectable advanced gastric cancer in Eastern countries. However, Western surgeons usually perform D1
2 or modified D2 (D1+) lymphadenectomy. 7 Several previous studies reported acceptable ranges of postoperative morbidity, mortality, and long-term survival rates after gastrectomy with D2 lymphadenectomy. However, there have been limited data about these surgical outcomes, specifically for TG with D2 lymphadenectomy, and the risk factors associated with these outcomes were unclear. In this study, we determined the postoperative morbidity, mortality, and long-term survival rates in patients who underwent TG with D2 lymphadenectomy. We further tried to identify the risk factors associated with these outcomes. This study would clarify whether the TG with D2 lymphadenectomy for gastric cancer is feasible and would help to riskstratify the patients undergoing TG with D2 lymphadenectomy for gastric cancer. Patients and Methods Patient Selection A total of 915 consecutive patients underwent gastrectomy for gastric cancer at the Gastrointestinal Surgical Department, The First Affiliated Hospital of Wenzhou Medical University between December 2008 and December Patients were excluded owing to subtotal gastrectomy (n = 566), TG but not D2 lymphadenectomy (n = 41), palliative surgery (n =73),and incomplete clinical data (n = 6). Therefore, the remaining 229 patients who underwent TG with D2 lymphadenectomy were included in this study. The surgeries were performed by nine surgeons whose operation quality was considered to be satisfactory after assessment by two professors in our department. No operations were performed laparoscopically. TG with D2 lymphadenectomy for gastric cancer was performed in accordance with the Japanese Gastric Cancer Treatment Guidelines. 4, 8 D2 Lymphadenectomy Procedure The lymph node stations included in D2 lymphadenectomy during total gastrectomy were nos. 1 7, 8a, 9, 10, 11p, 11d, and 12a. We performed spleen-preserved lymphadenectomy for no. 10 and no. 11d lymph nodes. The procedure is briefly described as follows. First, we mobilized the spleen and pancreatic tail by dissecting all the ligamentous attachments. The spleen and pancreatic tail were mobilized to the level where inferior mesenteric vein confluences to splenic vein. Then, the spleen and pancreatic tail were moved outside from the abdominal cavity, and all the lymphatic fatty tissues at splenic hilum were carefully removed under direct vision. The splenic artery sheath was then opened close to the upper edge of the pancreas. The splenic vessels were denuded from distal to proximal. The lymphatic fatty tissues around splenic vessels were carefully dissected and removed. After the dissection, the spleen and pancreas were fixed to the original position. Splenectomy is performed when the tumor invades the spleen or the fatty and connective tissue of splenic hilum. Pancreatectomy is performed when the tumor invades or adheres to the pancreas. Data Collection Referring to our prospectively maintained computer database, the following data were analyzed retrospectively: (1) clinicopathological features, including age, gender, body mass index (BMI), the American Society of Anesthesiology (ASA) score, plasma albumin concentration, hemoglobin concentration, comorbidities, previous abdominal surgery, Lauren s histology type, tumor location, tumor size, tumor node metastasis (TNM) stage, lymphovascular invasion, and combined resection; (2) postoperative outcomes, including the postoperative complications, surgical mortality, length of hospital stay, disease-free survival (DFS), and overall survival (OS). All participants provided their written informed consent and the protocol for this study was approved by the ethics committee of The First Affiliated Hospital of Wenzhou Medical University. Definition A plasma albumin concentration <35 g/l was defined as hypoproteinemia. A hemoglobin concentration <120 g/l in men and <110 g/l in women was defined as anemia. Cardiopulmonary comorbidities were defined as the presence of cardiopulmonary disease(s) before surgery, including hypertension, cardiac disease (myocardial infarction or stenocardia), pneumonia, bronchitis, tuberculosis, chronic obstructive pulmonary disease (COPD), pleural effusion, and asthma. Postoperative complications were defined as morbidities that occurred within 30 days of the operation, and those classified as grade II or above according to the Clavien-Dindo classification 9 were included in the univariate and multivariate analyses. Surgical mortality was defined as death within 30 or 90 days after surgical resection. The DFS was defined as the time between 90 days after surgery and the date of local/ distant recurrence or the date of last follow-up. The OS was defined as the time from the date of surgery to the date of death or the date of last follow-up. Follow-Up Strategies All patients were followed-up within the first month after surgery,every3monthsfor2years,every6monthsforup to 5 years, and every 1 year until the end of the study period or death. The follow-up program consisted of a physical examination, laboratory tests, and endoscopy, and/or
3 ultrasonography, and/or computed tomography. The last follow-up date was March Statistical Analysis Continuous variables were presented as the mean and standard deviation (normally distributed variables) or median and interquartile range (non-normally distributed variables). Categorical variables were presented as numbers and percentages. Clinical variables were compared using the Student t test (normally distributed data), the Pearson chi square test or Fisher exact test (categorical data), and the Mann-Whitney U test (ranked data) as appropriate. The survival analysis was undertaken using the Kaplan-Meier method, and the comparison of curves was performed using a log-rank test. Variables with a value of P < 0.10 in the univariate analyses were included in the subsequent multivariate (logistic regression or Cox proportional hazards regression) analyses. All tests were twosided, and differences were considered to be statistically significant at P < The statistical analyses were performed using the SPSS statistics version 22.0 (IBM, Armonk, NY, USA) and GraphPad Prism 5.0 (GraphPad Software Inc., CA, USA) software programs. Results Patient Population The clinicopathological characteristics are summarized in Table 1. A total of 229 patients were included in this study. The present patient cohort had an average age of 65.0 years old, and 85.2 % of them were male. The mean BMI of the study population was 21.7 kg/m 2. The distribution of the TNM stages in the patients was 28 (12.2 %), 44 (19.2 %), and 157 (68.6 %) for TNM stages I, II, and III, respectively. The most common comorbidities were cardiopulmonary comorbidities (25.3 %, n = 58), obesity (10.9 %, n = 25), and diabetes (7.4 %, n =17). Short-Term Surgical Outcomes As shown in Table 2, the incidence of any complications was 22.3 %, and complications classified as grade II or above were observed in 20.0 % of the patients. The median postoperative hospital stay was 12 days (range, days). The most common complications were pneumonia (7.4 %, n = 17) and wound infection (7.0 %, n = 16). None of the patients died within 30 days, while six patients (2.6 %) died within 90 days of the operation. The causes of death were respiratory failure induced by pneumonia (two patients), anastomotic leakage (two patients), intra-abdominal hemorrhage (one patient), Table 1 Patient demographic and clinical characteristics Factors Frequency, n Patients, % Age, mean (SD), years 65.0 (11.0) Gender Female Male BMI, mean (SD), kg/m (2.8) Albumin, mean (SD), g/l (5.23) Hemoglobin, median (IQR), g/l ( ) 11.8 Median no. of retrieved lymph 26 (18 57) nodes, range BMI < > ASA grade I II III Diabetes No Yes Cardiopulmonary comorbidities No Yes Previous abdominal surgery No Yes Histologic type Differentiated a Undifferentiated b Tumor size (diameter) <5 cm cm T category T T T T Ncategory N N N N Tumor location Not upper Upper c TNM stage I II III
4 Table 1 (continued) Table 2 Short- and long-term outcomes Factors Frequency, n Patients, % Lymphovascular invasion No Yes Any additional organ resection d No Yes R0 resection No Yes BMI body mass index, ASA American Society of Anesthesiologists, SD standard deviation, IQR interquartile range a Undifferentiated carcinomas include poorly differentiated adenocarcinomas, signet ring cell carcinomas, and mucinous carcinomas b Differentiated carcinomas include well or moderately differentiated, tubular, or papillary adenocarcinomas c Tumor located in the upper of the stomach d Splenectomy and/or pancreatectomy and septic shock induced by intra-abdominal abscess from other causes (one patient). The results of the univariate and multivariate analyses of factors associated with postoperative complications (grade II or above) are shown in Table 3. The results of the multivariate analysis revealed that the independent risk factors for postoperative complications (grade II or above) were age 65 years (OR = 3.638, P = 0.001) and cardiopulmonary comorbidities (OR = 2.189, P =0.036). Long-Term Survival Outcomes As shown in Table 2, among the 229 patients, survival data were available for 224 patients. Five patients were lost to follow-up, giving a follow-up rate of 97.8 % (224/229) for the evaluation. The median follow-up period was months (range months). One hundred twenty-four patients (54.1 %) died during the follow-up period. The median DFS was 35.7 months (95 % CI months), with a 1-, 3-, and 5-year DFS rates of 69.6, 49.1, and 43.0 %, respectively (Fig. 1a). The median OS was 41.1 months (95 % CI months), with a 1-, 3-, and 5-year OS rates of 79.8, 51.8, and 43.2 %, respectively (Fig. 1b). The results of the univariate and multivariate analyses of factors associated with the DFS and OS are shown in Table 4. The multivariate analysis revealed that hypoproteinemia (HR = 1.625, P = 0.021) and TNM stage III (HR = 3.291, P < 0.001) were independent risk factors for a poorer DFS. Similarly, hypoproteinemia (HR = 1.901, P = 0.002) and Factors Frequency, n Patients, % Total complications Grade II or above Grade III or above Grade I Grade II Grade III Grade IV Grade V 0 0 Detail of complications Wound infection Bleeding Intra-abdominal abscess Anastomotic leakage Bowel obstruction or ileus Pancreatic fistula Pneumonia Respiratory failure Thoracic cavity fluid collection or abscess Cardiac Others mortality mortality Postoperative hospital stays, median 12 ( ) (IQR), days Median DFS time, (95 % CI), months 35.7 ( ) DFS rate (%) 1-year year year 43.0 Median OS time, (95 % CI), months 41.1 ( ) OS rate (%) 1-year year year 43.2 TNM stage III (HR = 3.019, P < 0.001) were also independent risk factors for a worse OS. Patient Risk Stratification As shown in Table 5, the identified preoperative risk factors for postoperative complications (age 65 years and cardiopulmonary comorbidities) were used to risk-stratify patients. In patients who had no risk factors for postoperative complications, the complication rate was 10.3 % (95 % CI %). The complication rate increased to 20.2 % (95 % CI %) in those with one risk factor (age 65 years or cardiopulmonary comorbidities) and to 40.5 % (95 % CI 24.3
5 Table 3 Univariate and multivariate logistic regression analysis of risk factors for complications Factors Univariable analysis Multivariate analysis Complication a cases (%) P OR (95 % CI) Age * <65 11 (11.1) (26.9) ( ) Gender Male 42 (21.5) Female 4 (11.8) BMI < (29.6) (18.1) >25 6 (24.0) Hypoproteinemia No 35 (19.6) Yes 11 (22.0) Anemia No 18 (15.9) Yes 28 (24.1) ASA grade I II 43 (19.8) III 3 (16.7) Diabetes No 39 (19.4) Yes 7 (41.2) Cardiopulmonary * comorbidities No 28 (16.4) Yes 18 (31.0) ( ) Previous abdominal surgery No 40 (19.5) Yes 6 (25.0) Histologic type Differentiated b 15 (25.4) Undifferentiated c 31 (18.2) Tumor location Not upper 19 (15.6) Upper d 27 (25.2) TNM stage I 5 (17.9) II 6 (13.6) III 35 (22.3) Lymphovascular invasion No 26 (16.8) Yes 20 (27.0) P * * Table 3 (continued) Factors Univariable analysis Multivariate analysis 56.8 %) in those with both risk factors (age 65 years and cardiopulmonary comorbidities). Regarding the long-term survival rates, the identified preoperative risk factors for the DFS and OS (hypoproteinemia and TNM stage III) were used to risk-stratify patients. In patients without risk factors, the 5-year survival rates were 68.9 % (95 % CI %)fortheDFSand71.1% (95 % CI %) for the OS. When one risk factor was present (hypoproteinemia or TNM stage III), the 5-year survival rates decreased to 36.5 % (95 % CI %) for the DFS and 36.7 % (95 % CI %) for the OS. When both risk factors were present (hypoproteinemia and TNM stage III), the 5-year survival rates further decreased to 20.2%(95%CI %) for the DFS and 22.9 % (95 % CI %) for the OS (Fig. 1c, d). Discussion Complication a cases (%) Any additional organ resection e No 42 (19.8) Yes 4 (23.5) P OR (95 % CI) Values in parentheses are percentages unless indicated otherwise BMI body mass index, ASA American Society of Anesthesiologists, SD standard deviation, IQR interquartile range *Statistically significant (P < 0.05) a Grade II or above b Undifferentiated carcinomas include poorly differentiated adenocarcinomas, signet ring cell carcinomas, and mucinous carcinomas c Differentiated carcinomas include well or moderately differentiated, tubular, or papillary adenocarcinomas d Tumor located in the upper of the stomach e Splenectomy and/or pancreatectomy According to the Japanese treatment guideline for gastric cancer issued by the Japanese Gastric Cancer Association (JGCA), TG with a proper extent of lymphadenectomy should be adopted for tumors located in the upper third of the stomach or advanced gastric cancer extending to the cardia. In several previous studies specifically analyzing TG, the short-term morbidity and mortality rates ranged from 13 to 38 % and 2 to 8.5 %, respectively, and many studies have reported a higher complication rate after TG compared with subtotal gastrectomy, 5, 6, leading to TG being considered a more invasive surgical procedure. With regard to lymph node dissection, a previously published Dutch trial indicated that D2 P
6 Fig. 1 Kaplan-Meier survival curves for disease-free survival (a) and overall survival (b). Comparison of disease-free survival rates (c) and comparison of overall survival rates (d) according to the presence or absence of risk factors (2 risk factors, 1 risk factor, 0 risk factor) lymphadenectomy was associated with lower locoregional recurrence and gastric cancer-related death rates than D1 lymphadenectomy after a median follow-up of 15 years. 13 However, two randomized clinical trials from Europe indicated that D2 lymphadenectomy did not lead to any long-term survival benefit compared with D1 lymphadenectomy. 14, 15 In addition, a recent study demonstrated that modified D2 (D1+) lymphadenectomy confers the same oncological adequacy as standard D2 lymphadenectomy, with a significant reduction of the postoperative morbidity. 7 Currently, D2 lymphadenectomy is widely accepted as the standard procedure for advanced gastric cancer in Eastern countries. On the contrary, Western surgeons usually perform D1 or modified D2 (D1+) lymphadenectomy due to fears about increasing the short-term morbidity and mortality by D2 lymphadenectomy. 16, 17 Therefore, it remains to be proven whether TG with D2 lymphadenectomy, a procedure comprising two factors that are both generally considered to be more invasive, is feasible. Although numerous studies have reported the postoperative morbidity, mortality, and long-term survival rates for TG in general, few have described these postoperative outcomes specifically for TG with D2 lymphadenectomy, and the risk factors associated with these outcomes were also unclear. In this study, we observed that 22.3 % of the patients developed postoperative complications within 30 days of the operation, but none of the patients died within 30 days, and six patients (2.6 %) died within 90 days of the operation. Cuschieri et al. reported morbidity and mortality rates of 46 and 13 %, respectively. 17 The Dutch trial conducted at 80 different centers in the Netherlands reported a morbidity rate of 43 % and a mortality rate of 10 %. 16 In view of the similar age range, the higher proportion of males, and the more advanced tumor stages of our study compared with these previous studies, we considered that our postoperative morbidity and mortality rates were satisfactory. The difference in the morbidity and mortality rates can be partially explained by the fact that our study is based on the data from a single large center that specializes in gastric cancer surgery. Numerous studies have demonstrated that the postoperative surgical outcomes may vary according to the volume of surgery and surgical specialization Therefore, we considered that the postoperative morbidity and mortality rates and the results of the univariate and multivariate analyses in this study were reliable. Based on these morbidity and mortality rates, we believe that TG with D2 lymphadenectomy is feasible for the treatment of gastric cancer. However, due to the retrospective design of this study, further prospective studies are needed to demonstrate the feasibility of TG with D2 lymphadenectomy in the future. Both the 30-day and 90-day mortality rates were reported in this study because surgery-related mortality after major abdominal surgery has been found to occur up to 90 days postoperatively. 21, 22 Our results showed that none of the patients died within 30 days, whereas six patients (2.6 %) died within 90 days of the operation. Thus, our results indicated that using the 30-day mortality rate may lead to an underestimation of the true postoperative mortality rate. Unfortunately, none of the previous studies specifically reported the 90-day mortality, so we were unable to compare the 90-day mortality rates directly. We propose that both the 30-day and 90-day mortality rates should be reported to better reflect the surgical mortality in the future studies. Age 65 years was found to be an independent risk factor associated with increased morbidity in the present study,
7 Table 4 Univariate and multivariate analysis of risk factors for disease-free and overall survival Factors Disease-free survival Overall survival Univariable analysis Multivariate analysis Univariable analysis Multivariate analysis 5-year DFS (%) P HR (95 % CI) P 5-year OS (%) P HR (95 % CI) P Age * * < Gender Male Female BMI < > Hypoproteinemia * * No Yes ( ) * ( ) * Anemia * * No Yes ASA grade I, II III Diabetes No Yes Cardiopulmonary comorbidities No Yes Previous abdominal surgery No Yes Histologic type * Differentiated a Undifferentiated b Tumor location Not upper Upper c TNM stage * * I/II III ( ) 0.000* ( ) 0.000* Lymphovascular invasion * * No Yes Any additional organ resection b No Yes Values in parentheses are percentages unless indicated otherwise BMI body mass index, ASA American Society of Anesthesiologists, SD standard deviation, IQR interquartile range *Statistically significant (P < 0.05) a Undifferentiated carcinomas include poorly differentiated adenocarcinomas, signet ring cell carcinomas, and mucinous carcinomas b Differentiated carcinomas include well or moderately differentiated, tubular, or papillary adenocarcinomas c Tumor located in the upper of the stomach d Splenectomy and/or pancreatectomy
8 Table 5 Morbidity and survival by preoperative risk factors Frequency, n Morbidity rate, % 5-year survival rate, % Patient morbidity risk factors < / / / Patient DFS risk factors < Patient OS risk factors < which is similar to the findings of the Dutch trial. 23 In general, elderly patients are more likely to have a functional diminution of their reserve capacity. Two previous studies have reported that elderly patients tended to experience more postoperative complications than younger patients due to their poorer physical function. 24, 25 In addition, another identified risk factor associated with morbidity in this study was cardiopulmonary comorbidities, which was also consistent with previous reports showing that cardiopulmonary comorbidities are one of the risk factors for the occurrence of complications after gastrectomy Therefore, careful patient selection for TG with D2 lymphadenectomy is warranted in elderly patients, particularly in those with cardiopulmonary comorbidities. Forpatientswithbothriskfactors(age 65 years and cardiopulmonary comorbidities), we further investigated whether changing to subtotal gastrectomy (STG) could decrease complication rate. Therefore, for the elderly patients with cardiopulmonary comorbidities, we compared the complication rate between those who underwent TG with D2 lymphadenectomy and those who underwent STG with D2 lymphadenectomy (data not shown). There were no significant differences in the postoperative complication rate between the patients who underwent STG and those who underwent TG. We speculate that these two factors are likely to be the risk factors for complications after STG as well. Considering the adverse nutritional consequences and poor quality of life of TG, 29, 30 we suggest that STG should still be recommended for elderly patients with cardiopulmonary comorbidities instead of TG, with the prerequisite of obtaining a negative margin. In the present study, the median DFS and OS were 35.7 and 41.1 months, respectively, with a 5-year DFS rate of 43.0 % and an OS rate of 43.2 %, while 5-year OS rates were reported ranging between 23.4 % and 35.6 % in Western studies and were more than 60 % in Japan and Korea These differences in the prognosis after curative gastrectomy can P be attributed mainly to the tumor stage at the time of diagnosis. The diagnosis of gastric cancer in China and Western countries tends to be delayed, with patients being diagnosed at a more advanced TNM stage. In contrast, in Japan and Korea, early screening for gastric cancer using barium studies or upper endoscopy is recommended for individuals aged 40 years old and older, 37 leading to an earlier diagnosis of gastric cancer. Supporting this hypothesis, the proportion of TNM stage III was 68.6 % in this study and was % in the above Western studies, while it was % in the above Japanese and Korean studies Considering the more advanced TNM stage in this study, we considered our 5- year survival rates to be satisfactory. Therefore, we have further proven the feasibility of TG with D2 lymphadenectomy in terms of long-term survivals. We also investigated the risk factors for long-term survival. As shown by the multivariate analysis, hypoproteinemia and TNM stage III were independent risk factors for the DFS and OS. Hypoproteinemic patients have a poor nutritional status with a reduced reserve capacity due to the cancer growth and the degeneration of their physical function. A previous study reported that the albumin level is significantly correlated with the 5-year overall and relapse-free survival rates after curative surgery for colon cancer. 38 Moreover, another study demonstrated that nutritional support can provide a survival benefit to gastric cancer patients with Nutritional Risk Screening (NRS) score Similar to previous studies, 40, 41 we also identified an advanced TNM stage as an independent prognostic factor for the long-term survival in this study. The TNM stage is a factor that has long been known to influence the long-term prognosis of almost all types of malignant diseases. For the malnourished patients (patients with hypoproteinemia), we further investigated whether changing to STG could improve the survival rates. Therefore, for the patients with hypoproteinemia, we compared the survival rates adjusted by TNM stage between those who underwent TG with D2 lymphadenectomy and those who underwent STG with D2 lymphadenectomy (data not shown). We found that the patients who underwent STG generally tend to have better DFS or OS than those who underwent TG. This could be attributed to the adverse nutritional consequences of TG. Therefore, we suggest that STG, with the prerequisite of obtaining a negative margin, should be adopted instead of TG to achieve a better longterm survival for the patients with hypoproteinemia. The identified preoperative risk factors for postoperative complications (age 65 years and cardiopulmonary comorbidities) were then used to risk-stratify patients. The complication rate rose from 10.3 % in those without either risk factor to 40.5 % in patients with both risk factors. Similarly, we also used the identified risk factors for the long-term survival (hypoproteinemia and TNM stage III) to risk-stratify patients. The 5-year survival rates
9 decreased from 68.9 % (DFS) and 71.1 % (OS) in those withouteitherriskfactorto20.2%(dfs)and22.9%(os) in patients with both risk factors. Thus, patients with multiple risk factors had significantly higher morbidity rates and lower long-term survival rates, which would contribute to the patient selection for this surgical procedure. Furthermore, based on the identified risk factors, several measures could be adopted to reduce the postoperative morbidity and improve the long-term survival of patients undergoing this surgery. Because cardiopulmonary comorbidity was identified as an independent risk factor for postoperative complications, preoperative evaluation of the cardiopulmonary function is necessary for each patient. For those who have a reduced cardiopulmonary function, preoperative optimization measures such as smoking cessation, preoperative physiotherapy, and preoperative pulmonary rehabilitation should be recommended to reduce the risk of postoperative pulmonary complications. 42 Second, as hypoproteinemia was independently associated with DFS and OS, preoperative enteral/parenteral nutrition should be administered to patients who have a poor nutritional status, 39 which might be helpful to prolong the long-term survival rates. Third, although the tumor stage is not a controllable factor, an intensive follow-up strategy may allow for the early detection and timely treatment of cancer recurrence, which may contribute to improvements in the long-term survivals. 43 There are several limitations associated with the present study. First, this study had a retrospective design and was conducted in a single center, which may limit the generalization of its conclusions. However, our department is one of the largest gastric cancer centers in China, so our data remain representative. Second, the sample size of this study was relatively small. Therefore, a large prospective and multicenter study is essential to overcome these limitations. Conclusion In summary, this study demonstrated that TG with D2 lymphadenectomy for gastric cancer is a feasible procedure with acceptable postoperative morbidity and mortality rates and long-term survival rates. Age 65 years and cardiopulmonary comorbidities were the independent risk factors for postoperative complications, whereas hypoproteinemia and TNM stage III were independently associated with a poorer DFS and OS. These risk factors were used to risk-stratify the patients undergoing TG with D2 lymphadenectomy. Patients with multiple risk factors had significantly higher complication rates and lower long-term survival rates, which would contribute to the patient selection and improvement of the quality of this surgical procedure. Compliance with Ethical Standards All participants provided their written informed consent, and the protocol for this study was approved by the ethics committee of The First Affiliated Hospital of Wenzhou Medical University. Conflict of Interest interests. References The authors declare that they have no competing 1. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, CA Cancer J Clin. 2015; 65(2): Bray F, Ren JS, Masuyer E, et al. Global estimates of cancer prevalence for 27 sites in the adult population in Int J Cancer. 2013; 132(5): Kim JP. Current status of surgical treatment of gastric cancer. J Surg Oncol. 2002; 79(2): Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011; 14(2): Bozzetti F, Marubini E, Bonfanti G, et al. Total versus subtotal gastrectomy: surgical morbidity and mortality rates in a multicenter Italian randomized trial. The Italian Gastrointestinal Tumor Study Group. Ann Surg. 1997; 226(5): Gockel I, Pietzka S, Gonner U, et al. Subtotal or total gastrectomy for gastric cancer: impact of the surgical procedure on morbidity and prognosis analysis of a 10-year experience. Langenbecks Arch Surg. 2005; 390(2): Galizia G, Lieto E, De Vita F, et al. Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis. Surgery. 2015; 157(2): Japanese Gastric Cancer Association. Guidelines for diagnosis and treatment of carcinoma of the stomach. April 2004 edition. Available from: 9. Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009; 250(2): Bartlett EK, Roses RE, Kelz RR, et al. Morbidity and mortality after total gastrectomy for gastric malignancy using the American College of Surgeons National Surgical Quality Improvement Program database. Surgery. 2014; 156(2): Watanabe M, Miyata H, Gotoh M, et al. Total gastrectomy risk model: data from 20,011 Japanese patients in a nationwide internet-based database. Ann Surg. 2014; 260(6): Grossmann EM, Longo WE, Virgo KS, et al. Morbidity and mortality of gastrectomy for cancer in Department of Veterans Affairs Medical Centers. Surgery. 2002; 131(5): Songun I, Putter H, Kranenbarg EM, et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010; 11(5): Hartgrink HH, van de Velde CJ, Putter H, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol. 2004; 22(11): Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer. 1999; 79(9-10): Bonenkamp JJ, Hermans J, Sasako M, et al. Extended lymphnode dissection for gastric cancer. N Engl J Med. 1999; 340(12):
10 17. Cuschieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet. 1996; 347(9007): Birkmeyer JD, Stukel TA, Siewers AE, et al. Surgeon volume and operative mortality in the United States. N Engl J Med. 2003; 349(22): Chowdhury MM, Dagash H and Pierro A. A systematic review of the impact of volume of surgery and specialization on patient outcome. Br J Surg. 2007; 94(2): Finlayson EV, Goodney PP and Birkmeyer JD. Hospital volume and operative mortality in cancer surgery: a national study. Arch Surg. 2003; 138(7): Damhuis RA, Wijnhoven BP, Plaisier PW, et al. Comparison of 30- day, 90-day and in-hospital postoperative mortality for eight different cancer types. Br J Surg. 2012; 99(8): Tran TB, Worhunsky DJ, Norton JA, et al. Multivisceral Resection for Gastric Cancer: Results from the US Gastric Cancer Collaborative. Ann Surg Oncol Sasako M. Risk factors for surgical treatment in the Dutch Gastric Cancer Trial. Br J Surg. 1997; 84(11): Hsu JT, Liu MS, Wang F, et al. Standard radical gastrectomy in octogenarians and nonagenarians with gastric cancer: are shortterm surgical results and long-term survival substantial? J Gastrointest Surg. 2012; 16(4): Mikami J, Kurokawa Y, Miyazaki Y, et al. Postoperative gastrectomy outcomes in octogenarians with gastric cancer. Surg Today. 2015; 45(9): Seo SH, Hur H, An CW, et al. Operative risk factors in gastric cancer surgery for elderly patients. J Gastric Cancer. 2011; 11(2): Shin HS, Oh SJ and Suh BJ. Factors related to morbidity in elderly gastric cancer patients undergoing gastrectomies. J Gastric Cancer. 2014; 14(3): Wu CW, Lo SS, Shen KH, et al. Surgical mortality, survival, and quality of life after resection for gastric cancer in the elderly. World J Surg. 2000; 24(4): Bozzetti F, Ravera E, Cozzaglio L, et al. Comparison of nutritional status after total or subtotal gastrectomy. Nutrition. 1990; 6(5): Kim AR, Cho J, Hsu YJ, et al. Changes of quality of life in gastric cancer patients after curative resection: a longitudinal cohort study in Korea. Ann Surg. 2012; 256(6): Cunningham SC, Kamangar F, Kim MP, et al. Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution. J Gastrointest Surg. 2005; 9(5): Mickevicius A, Ignatavicius P, Markelis R, et al. Trends and results in treatment of gastric cancer over last two decades at single East European centre: a cohort study. BMC Surg. 2014; 14: Wang J, Sun Y and Bertagnolli MM. Comparison of gastric cancer survival between Caucasian and Asian patients treated in the United States: results from the Surveillance Epidemiology and End Results (SEER) database. Ann Surg Oncol. 2015; 22(9): Kim HH, Han SU, Kim MC, et al. Long-term results of laparoscopic gastrectomy for gastric cancer: a large-scale case-control and case-matched Korean multicenter study. J Clin Oncol. 2014; 32(7): Kimura A, Ogata K, Kogure N, et al. Outcome of laparoscopic gastrectomy with D1 plus lymph node dissection in gastric cancer patients postoperatively diagnosed with locally advanced disease or lymph node metastasis. Surg Endosc Park do J, Han SU, Hyung WJ, et al. Long-term outcomes after laparoscopy-assisted gastrectomy for advanced gastric cancer: a large-scale multicenter retrospective study. Surg Endosc. 2012; 26(6): Park HJ, Ahn JY, Jung HY, et al. Clinical characteristics and outcomes for gastric cancer patients aged years. Gastric Cancer. 2014; 17(4): Lai CC, You JF, Yeh CY, et al. Low preoperative serum albumin in colon cancer: a risk factor for poor outcome. Int J Colorectal Dis. 2011; 26(4): Qiu M, Zhou YX, Jin Y, et al. Nutrition support can bring survival benefit to high nutrition risk gastric cancer patients who received chemotherapy. Support Care Cancer. 2015; 23(7): Shen Z, Ye Y, Xie Q, et al. Effect of the number of lymph nodes harvested on the long-term survival of gastric cancer patients according to tumor stage and location: a 12-year study of 1,637 cases. Am J Surg Kim JH, Chin HM and Jun KH. Surgical outcomes and survival after gastrectomy in octogenarians with gastric cancer. J Surg Res. 2015; 198(1): Mortensen K, Nilsson M, Slim K, et al. Consensus guidelines for enhanced recovery after gastrectomy: Enhanced Recovery After Surgery (ERAS(R)) Society recommendations. Br J Surg. 2014; 101(10): Hur H, Song KY, Park CH, et al. Follow-up strategy after curative resection of gastric cancer: a nationwide survey in Korea. Ann Surg Oncol. 2010; 17(1):54-64.
Satisfactory surgical outcome of T2 gastric cancer after modified D2 lymphadenectomy
Original Article Satisfactory surgical outcome of T2 gastric cancer after modified D2 lymphadenectomy Shupeng Zhang 1, Liangliang Wu 2, Xiaona Wang 2, Xuewei Ding 2, Han Liang 2 1 Department of General
More informationImpact of conversion during laparoscopic gastrectomy on outcomes of patients with gastric cancer
JBUON 2017; 22(4): 926-931 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE Impact of conversion during laparoscopic gastrectomy on outcomes of
More informationApproaches to Surgical Treatment of Gastric Cancer. Byrne Lee, MD FACS Chief, Mixed Tumor Surgery Service
Approaches to Surgical Treatment of Gastric Cancer Byrne Lee, MD FACS Chief, Mixed Tumor Surgery Service Disclosures I do not have anything to disclose Outline Background Diagnosis Histology Staging Surgery
More informationComparison of lymph node number and prognosis in gastric cancer patients with perigastric lymph nodes retrieved by surgeons and pathologists
Original Article Comparison of lymph node number and prognosis in gastric cancer patients with perigastric lymph nodes retrieved by surgeons and pathologists Lixin Jiang, Zengwu Yao, Yifei Zhang, Jinchen
More informationClinicopathologic Characteristics and Prognosis of Gastric Cancer in Young Patients
Yonago Acta medica 2012;55:57 61 Clinicopathologic Characteristics and Prognosis of Gastric Cancer in Young Patients Hiroaki Saito, Seigo Takaya, Yoji Fukumoto, Tomohiro Osaki, Shigeru Tatebe and Masahide
More informationThe detection rate of early gastric cancer has been increasing owing to advances in
Focused Issue of This Month Sung Hoon Noh, MD, ph.d Department of Surgery, Yonsei University College of Medicine E - mail : sunghoonn@yuhs.ac J Korean Med Assoc 2010; 53(4): 306-310 Abstract The detection
More informationOptimal Extent of Lymphadenectomy for Gastric Adenocarcinoma: A 7-Institution Study of the US Gastric Cancer Collaborative
Optimal Extent of Lymphadenectomy for Gastric Adenocarcinoma: A 7-Institution Study of the US Gastric Cancer Collaborative Reese W. Randle, Wake Forest School of Medicine Douglas S. Swords, Wake Forest
More informationA study on clinicopathological features and prognostic factors of patients with upper gastric cancer and middle and lower gastric cancer.
Biomedical Research 2018; 29 (2): 365-370 ISSN 0970-938X www.biomedres.info A study on clinicopathological features and prognostic factors of patients with upper gastric cancer and middle and lower gastric
More informationOutcomes associated with robotic approach to pancreatic resections
Short Communication (Management of Foregut Malignancies and Hepatobiliary Tract and Pancreas Malignancies) Outcomes associated with robotic approach to pancreatic resections Caitlin Takahashi 1, Ravi Shridhar
More informationSubtotal versus total gastrectomy for T3 adenocarcinoma of the antrum
Gastric Cancer (2003) 6: 237 242 DOI 10.1007/s10120-003-0261-4 Original article 2003 by International and Japanese Gastric Cancer Associations Subtotal versus total gastrectomy for T3 adenocarcinoma of
More informationgastric cancer; lymph node dissection;
Yonago Acta Medica 18;61:175 181 Original Article Therapeutic Value of Lymph Node Dissection Along the Superior Mesenteric Vein and the Posterior Surface of the Pancreatic Head in Gastric Cancer Located
More informationPositive impact of adding No.14v lymph node to D2 dissection on survival for distal gastric cancer patients after surgery with curative intent
Original Article Positive impact of adding No.14v lymph node to D2 dissection on survival for distal gastric cancer patients after surgery with curative intent Yuexiang Liang 1,2 *, Liangliang Wu 1 *,
More informationResearch Article Survival Benefit of Adjuvant Radiation Therapy for Gastric Cancer following Gastrectomy and Extended Lymphadenectomy
International Surgical Oncology Volume 2012, Article ID 307670, 7 pages doi:10.1155/2012/307670 Research Article Survival Benefit of Adjuvant Radiation Therapy for Gastric Cancer following Gastrectomy
More informationSung-Soo Hong, Sang-Yong Son, Ho-Jung Shin, Long-Hai Cui, Hoon Hur, and Sang-Uk Han
pissn : 2093-582X, eissn : 2093-5641 J Gastric Cancer 2016;16(4):240-246 https://doi.org/10.5230/jgc.2016.16.4.240 Original Article Can Robotic Gastrectomy Surpass Laparoscopic Gastrectomy by Acquiring
More informationThe Royal Marsden. Surgery for Gastric and GE Junction Cancer: primary palliative when and where? William Allum Consultant Surgeon
The Royal Marsden Surgery for Gastric and GE Junction Cancer: primary palliative when and where? William Allum Consultant Surgeon Any surgeon can cure Surgeon - dependent No surgeon can cure EMR D2 GASTRECTOMY
More informationIs Hepatic Resection Needed in the Patients with Peritoneal Side T2 Gallbladder Cancer?
Is Hepatic Resection Needed in the Patients with Peritoneal Side T2 Gallbladder Cancer? Lee H, Park JY, Youn S, Kwon W, Heo JS, Choi SH, Choi DW Department of Surgery, Samsung Medical Center Sungkyunkwan
More informationSurgical Treatment of Gastric Cancer
SMGr up Surgical Treatment of Gastric Cancer Igor Correia de Farias 1 *, Maria Luiza Leite de Medeiros 2, Wilson Luiz da Costa Júnior 1, Heber Salvador de Castro Ribeiro 1, Alessandro Landskron Diniz 1,
More informationHow many lymph nodes are enough? defining the extent of lymph node dissection in stage I III gastric cancer using the National Cancer Database
Original Article How many lymph nodes are enough? defining the extent of lymph node dissection in stage I III gastric cancer using the National Cancer Database Karna Sura, Hong Ye, Charles C. Vu, John
More informationRisk factors for lymph node metastasis in histologically poorly differentiated type early gastric cancer
498 Original article Risk factors for lymph node metastasis in histologically poorly differentiated type early gastric cancer Authors C. Kunisaki 1, M. Takahashi 2, Y. Nagahori 3, T. Fukushima 3, H. Makino
More informationPrognosis of Patients With Gastric Cancer Who Underwent Proximal Gastrectomy
Int Surg 2012;97:275 279 Prognosis of Patients With Gastric Cancer Who Underwent Proximal Gastrectomy Masahide Ikeguchi, Abdul Kader, Seigo Takaya, Youji Fukumoto, Tomohiro Osaki, Hiroaki Saito, Shigeru
More informationXiang Hu*, Liang Cao*, Yi Yu. Introduction
Original Article Prognostic prediction in gastric cancer patients without serosal invasion: comparative study between UICC 7 th edition and JCGS 13 th edition N-classification systems Xiang Hu*, Liang
More informationImpact of infectious complications on gastric cancer recurrence
Gastric Cancer (2015) 18:368 374 DOI 10.1007/s10120-014-0361-3 ORIGINAL ARTICLE Impact of infectious complications on gastric cancer recurrence Tsutomu Hayashi Takaki Yoshikawa Toru Aoyama Shinichi Hasegawa
More informationConventional Gastrectomy for Gastric Cancer. Franklin Wright UCHSC Department of Surgery Grand Rounds January 14, 2008
Conventional Gastrectomy for Gastric Cancer Franklin Wright UCHSC Department of Surgery Grand Rounds January 14, 2008 Overview Gastric Adenocarcinoma Conventional vs Radical Lymphadenectomy Non-randomized
More informationSignificance of the lymph nodes in the 7th station in rational dissection for metastasis of distal gastric cancer with different T categories
Original Article Significance of the lymph nodes in the 7th station in rational dissection for metastasis of distal gastric cancer with different T categories Wu Song, Yulong He, Shaochuan Wang, Weiling
More informationShort- and long-term outcomes of conversion in laparoscopic gastrectomy for gastric cancer
JBUON 2018; 23(4): 1004-1012 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE Short- and long-term outcomes of conversion in laparoscopic gastrectomy
More informationClinicopathological characteristics and outcomes in stage I III mucinous gastric adenocarcinoma: a retrospective study at a single medical center
Hsu et al. World Journal of Surgical Oncology (2016) 14:123 DOI 10.1186/s12957-016-0886-5 RESEARCH Open Access Clinicopathological characteristics and outcomes in stage I III mucinous gastric adenocarcinoma:
More informationRisk Factors and Tumor Recurrence in pt1n0m0 Gastric Cancer after Surgical Treatment
pissn : 293-582X, eissn : 293-5641 J Gastric Cancer 216;16(4):215-22 https://doi.org/1.523/jgc.216.16.4.215 Original Article Risk Factors and Tumor Recurrence in pt1nm Gastric Cancer after Surgical Treatment
More informationMATERIALS AND METHODS Patients
Yonago Acta medica 216;59:232 236 Original Article Usefulness of T-Shaped Gauze for Precise Dissection of Supra-Pancreatic Lymph Nodes and for Reduced Postoperative Pancreatic Fistula in Patients Undergoing
More informationDoes the Retrieval of at Least 15 Lymph Nodes Confer an Improved Survival in Patients with Advanced Gastric Cancer?
J Gastric Cancer 2014;14(2):111-116 http://dx.doi.org/10.5230/jgc.2014.14.2.111 Original Article Does the Retrieval of at Least 15 Lymph Nodes Confer an Improved Survival in Patients with Advanced Gastric
More informationEfficacy of prophylactic splenectomy for proximal advanced gastric cancer invading greater curvature
Ohkura et al. World Journal of Surgical Oncology (2017) 15:106 DOI 10.1186/s12957-017-1173-9 RESEARCH Open Access Efficacy of prophylactic splenectomy for proximal advanced gastric cancer invading greater
More informationLaparoscopic versus open total gastrectomy for advanced proximal gastric carcinoma: a matched pair analysis
JBUO 2016; 21(4): 903-908 ISS: 1107-0625, online ISS: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGIAL ARTICLE Laparoscopic versus open total gastrectomy for advanced proximal gastric
More information290 Clin Oncol Cancer Res (2009) 6: DOI /s
290 Clin Oncol Cancer Res (2009) 6: 290-295 DOI 10.1007/s11805-009-0290-9 Analysis of Prognostic Factors of Esophageal and Gastric Cardiac Carcinoma Patients after Radical Surgery Using Cox Proportional
More informationClinical Study Impact of the Number of Dissected Lymph Nodes on Survival for Gastric Cancer after Distal Subtotal Gastrectomy
Gastroenterology Research and Practice Volume 2011, Article ID 476014, 7 pages doi:10.1155/2011/476014 Clinical Study Impact of the Number of Dissected Lymph Nodes on Survival for Gastric Cancer after
More informationA propensity score-matched case-control comparative study of laparoscopic and open gastrectomy for locally advanced gastric carcinoma
JBUON 2016; 21(1): 118-124 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE A propensity score-matched case-control comparative study of laparoscopic
More informationPrognostic Factors for Node-Negative Advanced Gastric Cancer after Curative Gastrectomy
pissn : 293-582X, eissn : 293-564 J Gastric Cancer 26;6(3):6-66 http://dx.doi.org/.523/jgc.26.6.3.6 Original Article Prognostic Factors for Node-Negative Advanced Gastric Cancer after Curative Gastrectomy
More informationAnalysis of the outcome of young age tongue squamous cell carcinoma
Jeon et al. Maxillofacial Plastic and Reconstructive Surgery (2017) 39:41 DOI 10.1186/s40902-017-0139-8 Maxillofacial Plastic and Reconstructive Surgery RESEARCH Open Access Analysis of the outcome of
More informationLog odds of positive lymph nodes is a novel prognostic indicator for advanced ESCC after surgical resection
Original Article Log odds of positive lymph nodes is a novel prognostic indicator for advanced ESCC after surgical resection Mingjian Yang 1,2, Hongdian Zhang 1,2, Zhao Ma 1,2, Lei Gong 1,2, Chuangui Chen
More informationAuthor s response to reviews Title: Robotic versus Laparoscopic Gastrectomy for Gastric Cancer: A Systematic Review and Updated Meta-analysis
Author s response to reviews Title: Robotic versus Laparoscopic Gastrectomy for Gastric Cancer: A Systematic Review and Updated Meta-analysis Authors: Ke Chen (chenke0301243@163.com) Yu Pan (panyu1013@126.com)
More informationJun Lu, Chang-Ming Huang, Chao-Hui Zheng, Ping Li, Jian-Wei Xie, Jia-Bin Wang, and Jian-Xian Lin
Oncology Volume 22, Article ID 6428, 7 pages doi:.55/22/6428 Research Article Analysis on the Clinical and Pathological Features and Prognosis of Familial Gastric Cancer in South China Population: A Single-Center
More informationSupplementary Information
Supplementary Information Prognostic Impact of Signet Ring Cell Type in Node Negative Gastric Cancer Pengfei Kong1,4,Ruiyan Wu1,Chenlu Yang1,3,Jianjun Liu1,2,Shangxiang Chen1,2, Xuechao Liu1,2, Minting
More informationESD for EGC with undifferentiated histology
ESD for EGC with undifferentiated histology Jun Haeng Lee, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Biopsy: M/D adenocarcinoma ESD: SRC >>
More informationLymph node ratio as a prognostic factor in stage III colon cancer
Lymph node ratio as a prognostic factor in stage III colon cancer Emad Sadaka, Alaa Maria and Mohamed El-Shebiney. Clinical Oncology department, Faculty of Medicine, Tanta University, Egypt alaamaria1@hotmail.com
More informationSplenic hilar dissection in the treatment of proximal advanced gastric cancer: what is an adequate strategy?
Editorial Splenic hilar dissection in the treatment of proximal advanced gastric cancer: what is an adequate strategy? Takahiro Kinoshita Gastric Surgery Division, National Cancer Center Hospital East,
More informationThe Royal Marsden. Surgery for Gastric and GE Junction Cancer: primary palliative when and where? William Allum
The Royal Marsden Surgery for Gastric and GE Junction Cancer: primary palliative when and where? William Allum The Royal Marsden William Allum Conflict of Interest None Any surgeon can cure Surgeon - dependent
More informationLong term survival study of de-novo metastatic breast cancers with or without primary tumor resection
Long term survival study of de-novo metastatic breast cancers with or without primary tumor resection Dr. Michael Co Division of Breast Surgery Queen Mary Hospital The University of Hong Kong Conflicts
More informationLaparoscopic gastrectomy in obese patients with gastric cancer
JBUON 27; 22(2): -6 ISSN: 7-62, online ISSN: 22-629 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE Laparoscopic gastrectomy in obese patients with gastric cancer Juan Tan, Shaihong Zhu
More informationWon Ho Han1, Amir Ben Yehuda2, Deok-Hee Kim1, Seung Geun Yang1, Bang Wool Eom1, Hong Man Yoon1, Young-Woo Kim1, Keun Won Ryu1 View this article at:
Original Article A comparative study of totally laparoscopic distal gastrectomy versus laparoscopic-assisted distal gastrectomy in gastric cancer patients: Short-term operative outcomes at a high-volume
More informationUtility of the Proximal Margin Frozen Section for Resection of Gastric Adenocarcinoma: A 7-Institution Study of the US Gastric Cancer Collaborative
Ann Surg Oncol (2014) 21:4202 4210 DOI 10.1245/s10434-014-3834-z ORIGINAL ARTICLE GASTROINTESTINAL ONCOLOGY Utility of the Proximal Margin Frozen Section for Resection of Gastric Adenocarcinoma: A 7-Institution
More informationPoor Prognosis of Advanced Gastric Cancer with Metastatic Suprapancreatic Lymph Nodes
Ann Surg Oncol (2013) 20:2290 2295 DOI 10.1245/s10434-012-2839-8 ORIGINAL ARTICLE GASTROINTESTINAL ONCOLOGY Poor Prognosis of Advanced Gastric Cancer with Metastatic Suprapancreatic Lymph Nodes Toru Kusano,
More informationCorrespondence to: Jiankun Hu, MD, PhD. Department of Gastrointestinal Surgery; Institute of Gastric Cancer, State Key Laboratory of.
Original Article Comparison of survival outcomes between transthoracic and transabdominal surgical approaches in patients with Siewert-II/III esophagogastric junction adenocarcinoma: a single-institution
More informationORIGINAL ARTICLE. International Journal of Surgery
International Journal of Surgery (2013) 11(S1), S90 S94 Contents lists available at ScienceDirect International Journal of Surgery journal homepage: www.journal-surgery.net ORIGINAL ARTICLE Lymph node
More informationTreatment Strategy for Non-curative Resection of Early Gastric Cancer. Jun Haneg Lee. Sungkyunkwan University, Samsung Medical Center, Seoul Korea
Treatment Strategy for Non-curative Resection of Early Gastric Cancer Jun Haneg Lee. Sungkyunkwan University, Samsung Medical Center, Seoul Korea Classic EMR/ESD data analysis style Endoscopic resection
More informationIs surgical Apgar score an effective assessment tool for the prediction of postoperative complications in patients undergoing oesophagectomy?
Interactive CardioVascular and Thoracic Surgery 27 (2018) 686 691 doi:10.1093/icvts/ivy148 Advance Access publication 9 May 2018 BEST EVIDENCE TOPIC Cite this article as: Li S, Zhou K, Li P, Che G. Is
More informationWhich Is the Optimal Extent of Resection in Middle Third Gastric Cancer between Total Gastrectomy and Subtotal Gastrectomy?
J Gastric Cancer 2010;10(4):226-233 DOI:10.5230/jgc.2010.10.4.226 Original Article Which Is the Optimal Extent of Resection in Middle Third Gastric Cancer between Total Gastrectomy and Subtotal Gastrectomy?
More informationTreatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy
Korean J Hepatobiliary Pancreat Surg 2011;15:152-156 Original Article Treatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy Suzy Kim 1,#, Kyubo
More informationTumor Size as a Prognostic Factor in Gastric Cancer Patient
J Gastric Cancer 2012;12(3):164-172 http://dx.doi.org/10.5230/jgc.2012.12.3.164 Original Article Tumor Size as a Prognostic Factor in Gastric Cancer Patient Won Jin Im, Min Gyu Kim, Tae Kyung Ha, and Sung
More informationRevisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis
Jpn J Clin Oncol 1997;27(5)305 309 Revisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis -, -, - - 1 Chest Department and 2 Section of Thoracic Surgery,
More informationسرطان المعدة. Gastric Cancer حمود حامد
سرطان المعدة Gastric Cancer ا أ لستاذ الدك تور حمود حامد عميد كلية الطب البشري بجامعة دمشق Epidemiology second leading cause of cancer death and fourth most common cancer worldwide Overall declining Histologic
More informationOutcome after emergency surgery in patients with a free perforation caused by gastric cancer
experimental and therapeutic medicine 1: 199-203, 2010 199 Outcome after emergency surgery in patients with a free perforation caused by gastric cancer Hironori Tsujimoto 1, Shuichi Hiraki 1, Naoko Sakamoto
More informationGASTRIC CANCER RANDOMIZED CONTROLLED TRIAL ON D2 LINPHADENECTOMY VS STANDARD D1 LINPHADENECTOMY
GASTRIC CANCER RANDOMIZED CONTROLLED TRIAL ON D2 LINPHADENECTOMY VS STANDARD D1 LINPHADENECTOMY Maurizio Degiuli, MD Coordinator of the IGCSG (Italian Gastric Cancer Study Group) Antonio Ponti, MD MPH
More informationThe Prognostic Value of Ratio-Based Lymph Node Staging in Resected Non Small-Cell Lung Cancer
Original Article The Prognostic Value of Ratio-Based Lymph Node Staging in Resected Non Small-Cell Lung Cancer Chen Qiu, MD,* Wei Dong, MD,* Benhua Su, MBBS, Qi Liu, MD,* and Jiajun Du, PhD Introduction:
More informationLaparoscopic splenic hilar lymphadenectomy for advanced gastric cancer
Review Article Laparoscopic splenic hilar lymphadenectomy for advanced gastric cancer Hisahiro Hosogi 1, Hiroshi Okabe 1,2, Hisashi Shinohara 1, Shigeru Tsunoda 1, Shigeo Hisamori 1, Yoshiharu Sakai 1
More informationBiomedical Research 2017; 28 (21): ISSN X
Biomedical Research 2017; 28 (21): 9497-9501 ISSN 0970-938X www.biomedres.info Analysis of relevant risk factor and recurrence prediction model construction of thyroid cancer after surgery. Shuai Lin 1#,
More informationCharacteristics and prognostic factors of synchronous multiple primary esophageal carcinoma: A report of 52 cases
Thoracic Cancer ISSN 1759-7706 ORIGINAL ARTICLE Characteristics and prognostic factors of synchronous multiple primary esophageal carcinoma: A report of 52 cases Mei Li & Zhi-xiong Lin Department of Radiation
More informationPrognostic Factors for Survival of Stage IB Upper Lobe Non-small Cell Lung Cancer Patients: A Retrospective Study in Shanghai, China
www.springerlink.com Chin J Cancer Res 23(4):265 270, 2011 265 Original Article Prognostic Factors for Survival of Stage IB Upper Lobe Non-small Cell Lung Cancer Patients: A Retrospective Study in Shanghai,
More informationPerigastric lymph node metastases in gastric cancer: comparison of different staging systems
Gastric Cancer (1999) 2: 201 205 Original article 1999 by International and Japanese Gastric Cancer Associations Perigastric lymph node metastases in gastric cancer: comparison of different staging systems
More informationGuidelines for Extended Lymphadenectomy in Gastric Cancer: A Prospective Comparative Study
Ann Surg Oncol DOI 10.1245/s10434-012-2544-7 ORIGINAL ARTICLE GASTROINTESTINAL ONCOLOGY Guidelines for Extended Lymphadenectomy in Gastric Cancer: A Prospective Comparative Study Oktar Asoglu, MD 1, Tugba
More informationValidation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer
Original Article Validation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer Hee Suk Jung 1, Jin Gu Lee 2, Chang Young Lee 2, Dae Joon Kim 2, Kyung Young Chung 2 1 Department
More informationThree-dimensional computed tomography simulation for laparoscopic lymph node dissection in the treatment of proximal gastric cancer
Review Article Three-dimensional computed tomography simulation for laparoscopic lymph node dissection in the treatment of proximal gastric cancer Hideki Sunagawa, Takahiro Kinoshita Gastric Surgery Division,
More informationPostoperative morbidity in elderly patients after gastric cancer surgery
ORIGINAL ARTICLE Annals of Gastroenterology (2018) 31, 1-7 Postoperative morbidity in elderly patients after gastric cancer surgery Tomoyuki Wakahara, Nozomi Ueno, Tetsuo Maeda, Kiyonori Kanemitsu, Takuro
More informationOutcomes of Patients with Preoperative Weight Loss following Colorectal Surgery
Outcomes of Patients with Preoperative Weight Loss following Colorectal Surgery Zhobin Moghadamyeghaneh MD 1, Michael J. Stamos MD 1 1 Department of Surgery, University of California, Irvine Nothing to
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Adenocarcinoma, pancreatic ductal, laparoscopic distal pancreatectomy for, 61 Adrenal cortical carcinoma, laparoscopic adrenalectomy for, 114
More informationPeritoneal Involvement in Stage II Colon Cancer
Anatomic Pathology / PERITONEAL INVOLVEMENT IN STAGE II COLON CANCER Peritoneal Involvement in Stage II Colon Cancer A.M. Lennon, MB, MRCPI, H.E. Mulcahy, MD, MRCPI, J.M.P. Hyland, MCh, FRCS, FRCSI, C.
More informationRetrospectively analysis of the pathology and prognosis of 131 cases of adenocarcinoma of the esophagogastric junction (Siewert type II/III)
Original Article Retrospectively analysis of the pathology and prognosis of 131 cases of adenocarcinoma of the esophagogastric junction (Siewert type II/III) Zifeng Yang*, Junjiang Wang*, Deqing Wu, Jiabin
More informationPOLSKI 2013, 85, 8,
POLSKI PRZEGLĄD CHIRURGICZNY 2013, 85, 8, 433 437 10.2478/pjs-2013-0066 Morbidity, mortality and survival after stomach resection with or without splenectomy the single centre observations Zoran Stojcev
More informationRecent Evolution of Surgical Treatment for Gastric Cancer in Korea
J Gastric Cancer 2011;11(1):1-6 DOI:10.5230/jgc.2011.11.1.1 Review Article Recent Evolution of Surgical Treatment for Gastric Cancer in Korea Ji Yeong An, Jae-Ho Cheong, Woo Jin Hyung, and Sung Hoon Noh
More informationLaparoscopy-assisted D2 radical distal subtotal gastrectomy
Masters of Gastrointestinal Surgery Laparoscopy-assisted D2 radical distal subtotal gastrectomy Xiaogeng Chen, Weihua Li, Jinsi Wang, Changshun Yang Department of Tumor Surgery, Fujian Provincial Hospital,
More informationExpression of mir-1294 is downregulated and predicts a poor prognosis in gastric cancer
European Review for Medical and Pharmacological Sciences 2018; 22: 5525-5530 Expression of mir-1294 is downregulated and predicts a poor prognosis in gastric cancer Y.-X. SHI, B.-L. YE, B.-R. HU, X.-J.
More informationSafety of pancreatic resection in the elderly: a retrospective analysis of 556 patients
ORIGINAL ARTICLE Annals of Gastroenterology (2016) 29, 1-5 Safety of pancreatic resection in the elderly: a retrospective analysis of 556 patients Daniel Ansari, Linus Aronsson, Joakim Fredriksson, Bodil
More informationComparative study of clinical efficacy of laparoscopy-assisted radical gastrectomy versus open radical gastrectomy for advanced gastric cancer
Comparative study of clinical efficacy of laparoscopy-assisted radical gastrectomy versus open radical gastrectomy for advanced gastric cancer L.M. Wu, X.J. Jiang, Q.F. Lin and C.X. Jian Department of
More informationOriginal Article Is there an association between ABO blood group and overall survival in patients with esophageal squamous cell carcinoma?
Int J Clin Exp Med 2014;7(8):2214-2218 www.ijcem.com /ISSN:1940-5901/IJCEM0001278 Original Article Is there an association between ABO blood group and overall survival in patients with esophageal squamous
More informationGastric cancer treatment: similarity and difference between China and Korea
Review Article Gastric cancer treatment: similarity and difference between China and Korea Kun Yang 1,2, Jian-Kun Hu 1,2 1 Department of Gastrointestinal Surgery, West China Hospital, Sichuan University,
More informationExtended multi-organ resection for ct4 gastric carcinoma: A retrospective analysis
Original Article Extended multi-organ resection for ct4 gastric carcinoma: A retrospective analysis 1. Longbin Xiao, 2. Mingzhe Li, 3. Fengfeng Xu, Department of General Surgery I, 4. Huishao Ye, Department
More informationMichael A. Choti, MD, FACS Department of Surgery Johns Hopkins Medicine, Baltimore, MD
Michael A. Choti, MD, FACS Department of Surgery Johns Hopkins Medicine, Baltimore, MD Surgical Therapy of Gastric Cancer CLINICAL QUESTIONS 1. How much of the stomach should be removed? 2. How many lymph
More informationClinical Study Learning Curve for D2 Lymphadenectomy in Gastric Cancer
ISRN Surgery Volume 2013, Article ID 508719, 6 pages http://dx.doi.org/10.1155/2013/508719 Clinical Study Learning Curve for in Gastric Cancer Alexis Luna, Pere Rebasa, Sandra Montmany, and Salvador Navarro
More informationAlthough the international TNM classification system
Prognostic Significance of Perioperative Serum Carcinoembryonic Antigen in Non-Small Cell Lung Cancer: Analysis of 1,000 Consecutive Resections for Clinical Stage I Disease Morihito Okada, MD, PhD, Wataru
More informationImaging in gastric cancer
Imaging in gastric cancer Gastric cancer remains a deadly disease because of late diagnosis. Adenocarcinoma represents 90% of malignant tumors. Diagnosis is based on endoscopic examination with biopsies.
More informationExtent of visceral pleural invasion and the prognosis of surgically resected node-negative non-small cell lung cancer
Thoracic Cancer ISSN 1759-7706 ORIGINAL ARTICLE Extent of visceral pleural invasion and the prognosis of surgically resected node-negative non-small cell lung cancer Yangki Seok 1, Ji Yun Jeong 2 & Eungbae
More informationCharacteristics of intramural metastasis in gastric cancer. Tatsuya Hashimoto Kuniyoshi Arai Yuichi Yamashita Yoshiaki Iwasaki Tsunekazu
ORIGINAL ARTICLE Characteristics of intramural metastasis in gastric cancer Tatsuya Hashimoto Kuniyoshi Arai Yuichi Yamashita Yoshiaki Iwasaki Tsunekazu Hishima Author for correspondence: T. Hashimoto
More informationLong-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules
Long-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules YASUHIRO ITO, TAKUYA HIGASHIYAMA, YUUKI TAKAMURA, AKIHIRO MIYA, KAORU KOBAYASHI, FUMIO MATSUZUKA, KANJI KUMA
More informationSurgical resection improves survival in pancreatic cancer patients without vascular invasion- a population based study
Original article Annals of Gastroenterology (2013) 26, 346-352 Surgical resection improves survival in pancreatic cancer patients without vascular invasion- a population based study Subhankar Chakraborty
More informationA Proposed Strategy for Treatment of Superficial Carcinoma. in the Thoracic Esophagus Based on an Analysis. of Lymph Node Metastasis
Kitakanto Med J 2002 ; 52 : 189-193 189 A Proposed Strategy for Treatment of Superficial Carcinoma in the Thoracic Esophagus Based on an Analysis of Lymph Node Metastasis Susumu Kawate,' Susumu Ohwada,'
More informationPatient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival
MOLECULAR AND CLINICAL ONCOLOGY 7: 1083-1088, 2017 Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival FARUK TAS
More informationThe Predictors and Clinical Impact of Positive Resection Margins on Frozen Section in Gastric Cancer Surgery
J Gastric Cancer 2012;12(2):113-119 http://dx.doi.org/10.5230/jgc.2012.12.2.113 Original Article The Predictors and Clinical Impact of Positive Resection Margins on Frozen Section in Gastric Cancer Surgery
More informationImplications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers
日大医誌 75 (1): 10 15 (2016) 10 Original Article Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers Naotaka Uchida 1), Yasuki Matsui 1), Takeshi Notsu 1) and Manabu
More informationThe right middle lobe is the smallest lobe in the lung, and
ORIGINAL ARTICLE The Impact of Superior Mediastinal Lymph Node Metastases on Prognosis in Non-small Cell Lung Cancer Located in the Right Middle Lobe Yukinori Sakao, MD, PhD,* Sakae Okumura, MD,* Mun Mingyon,
More informationCitation for published version (APA): Bartels, S. A. L. (2013). Laparoscopic colorectal surgery: beyond the short-term effects
UvA-DARE (Digital Academic Repository) Laparoscopic colorectal surgery: beyond the short-term effects Bartels, S.A.L. Link to publication Citation for published version (APA): Bartels, S. A. L. (2013).
More informationSafety of Laparoscopy Assisted Gastrectomy for Gastric Cancer, Including Advanced Cancers
ORIGINAL ARTICLE pissn 2234-778X eissn 2234-5248 J Minim Invasive Surg 215;18(3):79-85 Journal of Minimally Invasive Surgery Safety of Laparoscopy Assisted Gastrectomy for Gastric Cancer, Including Advanced
More informationJi et al. BMC Cancer (2017) 17:345 DOI /s
Ji et al. BMC Cancer (2017) 17:345 DOI 10.1186/s12885-017-3343-0 RESEARCH ARTICLE Open Access The optimal extent of gastrectomy for middle-third gastric cancer: distal subtotal gastrectomy is superior
More informationLocoregional treatment Session Oral Abstract Presentation Saulo Brito Silva
Locoregional treatment Session Oral Abstract Presentation Saulo Brito Silva Background Post-operative radiotherapy (PORT) improves disease free and overall suvivallin selected patients with breast cancer
More information